|
- Home | Biogen
We came to Biogen to solve the unsolvable We stay to create new possibilities and grow together We work fearlessly and go beyond because we care deeply about making a difference and changing lives
- Company | Biogen
Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities
- Biogen Reports Second Quarter 2025 Results | Biogen
Biogen International Explore Stories Disease Areas Pipeline We recommend Biogen Foundation ESG Report Reporting and Principles Access Health Equity
- Mission and Culture - Biogen
The Biogen Way describes the mission and behaviors that provide the foundation for Biogen’s next era It is rooted in the company’s birth in 1978, when a group of accomplished scientists and a few venture capitalists formed a new company with an emphasis on breakthroughs in biology
- Pipeline | Biogen
Biogen is dedicated to addressing challenging diseases by leveraging cutting-edge science and driving an innovative pipeline of potential breakthrough therapies in neurology, immunology, and rare diseases
- Our U. S. Legacy | Biogen
Headquartered in Cambridge, Massachusetts, Biogen is one of the oldest independent American biotechnology companies We are North Carolina’s largest biotech employer and among the top five biopharmaceutical employers in the state, where our primary manufacturing operations are located
- News - Biogen
Biogen and Stoke Therapeutics Announce Presentation of Data from Studies of Zorevunersen, an Investigational Medicine for Dravet syndrome, at the 16th European Paediatric Neurology Society (EPNS) Congress
- Investor Relations | Biogen
Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patient’s lives and to create value for shareholders and our communities
|
|
|